A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection

详细信息    查看全文

• 作者：Saadettin Kilickap (1)
  Ayse Kars (1)
  Erhan Hamaloglu (2)
  Halis Simsek (3)
  
• 关键词：Hepatocellular cancer ; Metastasis ; Immunotherapy ; Antiviral therapy ; Prolonged survival
• 刊名：Medical Oncology
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：26
• 期：4
• 页码：501-505
• 全文大小：254KB
• 参考文献：1. Katyal S, Oliver JHIII, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000;216:698鈥?03.
  2. Shuto T, Hirohashi K, Kubo S, Tanaka H, Yamamoto T, Higaki I, et al. Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg. 2001;18:294鈥?. doi:10.1159/000050155 . CrossRef
  3. Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20:1781鈥?. doi:10.1111/j.1440-1746.2005.03919.x . CrossRef
  4. Giovannini M, Elias D, Monges G, Raoul JL, Rougier P. Hepatocellular carcinoma. Br J Cancer. 2001;84:74鈥?. doi:10.1054/bjoc.2001.1769 . CrossRef
  5. Moffat DF, Oien KA, Dickson J, Habeshaw T, McLellan DR. Hepatocellular carcinoma after long-term tamoxifen therapy. Ann Oncol. 2000;11:1195鈥?. doi:10.1023/A:1008354429921 . CrossRef
  6. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol. 2001;19:3037鈥?4.
  7. Llovet J, Ricci S, Mazzaferro V, Hilgard P, Raoul J, Zeuzem S, et al. Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): results of a phase III randomized placebocontrolled trial. J Clin Oncol. 2007;25:LBA1.
  8. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153鈥?. doi:10.1002/ijc.1440 . CrossRef
  9. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S294鈥?08. doi:10.1111/j.1440-1746.1997.tb00513.x . CrossRef
  10. Chen PJ, Chen DS. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives. Semin Liver Dis. 1999;19:253鈥?2. CrossRef
  11. Si MS, Amersi F, Golish SR, Ortiz JA, Zaky J, Finklestein D, et al. Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg. 2003;69:879鈥?5.
  12. Tang ZY. Hepatocellular carcinoma鈥攃ause, treatment and metastasis. World J Gastroenterol. 2001;7:445鈥?4.
  13. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, Apakupakul N, Tongyoo S. Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol. 2000;6:339鈥?3.
  14. McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:497鈥?03. doi:10.1097/00042737-200505000-00005 . CrossRef
  15. Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10聽cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol. 2003;10:1070鈥?. doi:10.1245/ASO.2003.03.072 . CrossRef
  16. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500鈥?. doi:10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O. CrossRef
  17. Zhou XD, Tang ZY, Yang BH, Ma ZC, Ye SL, Wu ZQ, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91:1479鈥?6. doi:10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0. CrossRef
  18. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg. 1998;85:1198鈥?00. doi:10.1046/j.1365-2168.1998.00846.x . CrossRef
  19. Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg. 1994;81:1019鈥?1. doi:10.1002/bjs.1800810730 . CrossRef
  20. Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology. 2003;37:1309鈥?9. doi:10.1053/jhep. 2003.50208 . CrossRef
  21. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Crax A, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102鈥?0. doi:10.1053/j.gastro.2003.10.048 . CrossRef
  22. Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, et al. Longterm clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol. 2005;42:188鈥?4. doi:10.1016/j.jhep. 2004.10.026 . CrossRef
  23. Suriawinata A, Xu R. An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis. 2004;24:77鈥?8. doi:10.1055/s-2004-860865 . CrossRef
  24. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus鈥攁 prospective study of 22707 men in Taiwan. Lancet. 1981;2:1129鈥?3. doi:10.1016/S0140-6736(81)90585-7 . CrossRef
  25. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Cirrhosis Asian Lamivudine Multicentre Study Group. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521鈥?1. doi:10.1056/NEJMoa033364 . CrossRef
  26. Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13:1083鈥?. doi:10.1097/00042737-200109000-00015 . CrossRef
  27. Aron M, Nair M, Hemal AK. Renal metastasis from primary hepatocellular carcinoma. A case report and review of the literature. Urol Int. 2004;73(1):89鈥?1. doi:10.1159/000078812 . CrossRef
  28. Shiozaki T, Hayakawa K, Tanikake M, Oida T, Hida S, Yasui H, et al. Accumulation of 99mTc-PMT in renal metastasis of hepatocellular carcinoma. Ann Nucl Med. 2003;17(4):333鈥?. CrossRef
  29. Hsu YB, Lee PH, Sheu JC, Chen DS, Hsu HC. Hepatocellular carcinoma with metastasis to the kidney: report of a case. J Formos Med Assoc. 1994;93(1):71鈥?.
  
• 作者单位：Saadettin Kilickap (1)
  Ayse Kars (1)
  Erhan Hamaloglu (2)
  Halis Simsek (3)
  
  1. Department of Medical Oncology, Hacettepe University Institute of Oncology, Sihhiye, Ankara, 06100, Turkey
  2. Department of General Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey
  3. Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey
  

文摘

Hepatocellular carcinoma (HCC) is the most frequent malignant tumour of the liver. The risk of HCC in chronically hepatitis B virus (HBV) infected individuals is approximately 100-fold higher than in the uninfected population. Despite all therapeutic advances, the benefit of systemic chemotherapy in patients with HCC has limited. But, the phase III clinical trial conducted in patients with advanced HCC treated with sorafenib has showed significant improvements in both overall and progression-free survival Metastasis from liver to extrahepatic tissues is reported to be quite uncommon and has a poor prognosis. Here we present a case of HCC which metastasized to the vertebrae, lung and kidney in order of appearance and controlled with immunotherapy and antiviral therapy following resection.